跳到正文

Larimar Therapeutics, Inc.(LRMR)内部人交易:高管与董事近期交易

过去 18 个月,共有 18 位内部人为 Larimar Therapeutics, Inc.(LRMR)报告了 79 笔 Form 4 交易(最近一笔 2026-10-01)。

日期内部人职务类型股数市值
2026-10-01Harlow John B. Jr.President and COO买入50,000$0
2026-07-08Hamilton Thomas Edward董事买入50,000$166,890
2026-03-02DEERFIELD MANAGEMENT COMPANY, L.P.董事买入1.1M$5.4M
2026-03-02DEERFIELD MANAGEMENT COMPANY, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Mgmt L.P.董事买入1.1M$5.4M
2026-03-02DEERFIELD PARTNERS, L.P.董事买入1.1M$5.4M
2026-03-02Flynn James E董事买入1.1M$5.4M
2026-03-02Deerfield Private Design Fund III, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Mgmt III, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Healthcare Innovations Fund, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Mgmt HIF, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Private Design Fund IV, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Mgmt IV, L.P.董事买入1.1M$5.4M
2026-03-02SHERMAN JEFFREY W董事买入5,000$25,000
2026-03-02Deerfield Mgmt L.P.董事买入1.1M$5.4M
2026-03-02DEERFIELD PARTNERS, L.P.董事买入1.1M$5.4M
2026-03-02Flynn James E董事买入1.1M$5.4M
2026-03-02Deerfield Private Design Fund III, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Mgmt III, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Healthcare Innovations Fund, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Mgmt HIF, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Private Design Fund IV, L.P.董事买入1.1M$5.4M
2026-03-02Deerfield Mgmt IV, L.P.董事买入1.1M$5.4M
2026-03-02DEERFIELD MANAGEMENT COMPANY, L.P.董事买入831,978$4.2M
2026-03-02Deerfield Mgmt L.P.董事买入831,978$4.2M

来源:SEC Form 4 申报文件 · 截至 2026-10-01